Invention Grant
- Patent Title: Compounds for the treatment of hepatitis C
-
Application No.: US13210776Application Date: 2011-08-16
-
Publication No.: US08765944B2Publication Date: 2014-07-01
- Inventor: Li-Qiang Sun , Eric Mull , Qian Zhao , Tao Wang , Zhongxing Zhang , Paul Michael Scola
- Applicant: Li-Qiang Sun , Eric Mull , Qian Zhao , Tao Wang , Zhongxing Zhang , Paul Michael Scola
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- Main IPC: C07D251/52
- IPC: C07D251/52 ; A61K31/53 ; A61P31/12
Abstract:
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20120213729A1 Compounds for the Treatment of Hepatitis C Public/Granted day:2012-08-23
Information query
